Clinical Trials Browser

Phase EARLY_PHASE1 × Turcot syndrome × Clear all

Turcot syndrome, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT04906382 2025-02-13

Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer

Phase EARLY_PHASE1 Terminated

2 enrolled

GastrointestinalGynecologic

Turcot syndrome, Colorectal Neoplasms, Hereditary Nonpolyposis, Endometrial Neoplasms

Clinical Trials

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer